Urs Erwin Gasser
#191,904
Most Influential Person Now
Researcher
Urs Erwin Gasser's AcademicInfluence.com Rankings
Urs Erwin Gassercomputer-science Degrees
Computer Science
#13443
World Rank
#14482
Historical Rank
Machine Learning
#6325
World Rank
#6447
Historical Rank
Artificial Intelligence
#6794
World Rank
#6939
Historical Rank
Database
#10637
World Rank
#11344
Historical Rank
Download Badge
Computer Science
Urs Erwin Gasser's Degrees
- PhD Computer Science University of Zurich
- Masters Computer Science University of Zurich
- Bachelors Computer Science University of Zurich
Similar Degrees You Can Earn
Why Is Urs Erwin Gasser Influential?
(Suggest an Edit or Addition)Urs Erwin Gasser's Published Works
Published Works
- Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine (2006) (68)
- Effect and safety of duodenal levodopa infusion in advanced Parkinson’s disease: a retrospective multicenter outcome assessment in patient routine care (2013) (60)
- A pilot Iron Substitution Programme in female blood donors with iron deficiency without anaemia (2011) (40)
- End‐digit preference in general practice: A comparison of the conventional auscultatory and electronic oscillometric methods (2008) (33)
- A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers (2006) (26)
- Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® (2013) (24)
- Dual-release formulation, a novel principle in l-dopa treatment of Parkinson’s disease (2001) (21)
- Clinical efficacy and tolerability of a new levodopa/benserazide dual-release formulation in parkinsonian patients. L-Dopa Dual-Release Study Group. (1997) (19)
- Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects. (1998) (19)
- COMT Inhibition by Tolcapone Further Improves Levodopa Pharmacokinetics when Combined with a Dual-Release Formulation of Levodopa/Benserazide (1999) (16)
- Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practice (2007) (15)
- Short‐ and long‐term effects of two emollients on itching and skin restoration in xerotic eczema (2018) (13)
- Pharmacokinetic Studies with a Dual-Release Formulation of Levodopa, a Novel Principle in the Treatment of Parkinson’s Disease (1998) (11)
- Rivaroxaban for Thromboprophylaxis After Nonelective Orthopedic Trauma Surgery in Switzerland. (2017) (10)
- Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® (2013) (8)
- Vitex agnus-castus extract (Ze 440) improves symptoms in women with menstrual cycle irregularities (2014) (7)
- Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain. (2015) (7)
- Prevention of Acute Radiation-Induced Skin Reaction with NPE® Camellia Sinensis Nonfermentatum Extract in Female Breast Cancer Patients Undergoing Postoperative Radiotherapy: A Single Centre, Prospective, Open-Label Pilot Study (2018) (4)
- Evaluation of the analgesic efficacy and short-term tolerance of a single 6 ml injection of hyaluronic acid (Suplasyn® 1-Shot) on osteoarthritis of the knee (2013) (2)
- Antidepressant therapy with moclobemide in primary care practice (1993) (1)
- P-2-69 Treatment of severe recurrent major depression: Comparative efficacy and tolerability of moclobemide and imipramine (1995) (0)
- Oral session 24 — Mouvement disorders (1) (2005) (0)
- MULTICENTER STUDY EVALUATING THE EFFICACY AND TOLERANCE OF MOCLOBEMIDE IN DEPRESSED PATIENTS TREATED BY GENERAL PRACTITIONERS (1992) (0)
- Vol. 41, 1999 (1999) (0)
- Depression, mood disorders:- treatment (1994) (0)
- Subject Index Vol. 41, 1999 (1999) (0)
- Inhibition of Chemoresistance in Primary Tumor Cells by Camellia sinensis non fermentatum Extract Noviphenone (NPE®) (2019) (0)
- PP240—Pharmaceutical quality of generic levodopa/benserazide products (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Urs Erwin Gasser?
Urs Erwin Gasser is affiliated with the following schools: